Meeting
2016 ASCO Annual Meeting
High-dose versus weekly cisplatin definitive chemoradiotherapy for HPV-related oropharyngeal squamous cell carcinoma of the head and neck.
Authors
Cesar Augusto Perez
James Graham Brown Cancer Ctr, Louisville, KY
Cesar Augusto Perez , Xiaoyong Wu , Mark J. Amsbaugh , Wederson M. Claudino , Mehran Yusuf , Teresa Roberts , Jorge Arturo Rios-Perez , Dharamvir Jain , Alfred Jenson , Sujita Khanal , Craig I. Silverman , Paul Tennant , Neal E Dunlap , Shesh Rai , Rebecca A. Redman
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Head and Neck Cancer
Track
Head and Neck Cancer
Sub Track
Local-Regional Disease
Citation
J Clin Oncol 34, 2016 (suppl; abstr 6074)
DOI
10.1200/JCO.2016.34.15_suppl.6074
Abstract #
6074
Poster Bd #
396
Abstract Disclosures
Similar Posters
Poster
2014 Gastrointestinal Cancers Symposium
A comparison of carboplatin with paclitaxel and cisplatinum with 5-fluorouracil in definitive chemoradiotherapy in esophageal cancer patients.
First Author: Judith Honing
Poster
2023 ASCO Annual Meeting
Impact of acute kidney injury on overall survival in postoperative patients with head and neck cancer who received chemoradiotherapy with cisplatin: A supplementary analysis of a phase II/III trial of JCOG1008.
First Author: Yoshinori Imamura
Poster
2023 ASCO Annual Meeting
A single-arm, multi-institutional, phase 2 study of a pembrolizumab-based organ preservation strategy for locally advanced larynx cancers: SMART-KEY (LACOG 0720) trial.
First Author: Thiago Bueno Oliveira Sr.
Poster
2023 ASCO Annual Meeting
Active bone marrow-sparing to reduce the incidence of grade 3+ acute hematologic toxicity in patients with locally advanced cervical cancer who receive chemoradiotherapy: A single-center prospective randomized controlled trial.
First Author: ShanBing Wang